Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Nephrons01:10

Nephrons

The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma happens...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Measured and Estimated Glomerular Filtration Rates and Risk of Adverse Health Outcomes.

JAMA·2026
Same author

Glomerular Filtration Markers: Current and Emerging Insights.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Medications Influencing Serum Cystatin C Independent of Measured GFR.

Journal of the American Society of Nephrology : JASN·2026
Same author

Determining baseline serum creatinine in harmonized criteria for kidney disease: unfinished business.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same author

Population-based estimated Glomerular Filtration Rate distributions and associated health outcomes provide opportunities for early identification of and primary prevention of chronic kidney disease.

Kidney international·2026
Same author

Metabolomic Changes After Bariatric Surgery Adjusted for Glomerular Filtration Rate Suggest Mechanisms of Kidney Protection.

Obesity (Silver Spring, Md.)·2025
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
関連記事をすべて見る

関連する実験動画

Updated: May 30, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

慢性腎臓病 慢性腎臓病は,慢性腎臓病で,慢性腎臓病は慢性腎臓病で,慢性腎臓病は慢性腎臓病で,慢性腎臓病は慢性腎臓病で,慢性腎臓病は慢性腎臓病です.

Andrew S Levey1, Josef Coresh

  • 1William B Schwartz Division of Nephrology, Tufts Medical Center, Boston, MA 02111, USA. alevey@tuftsmedicalcenter.org

Lancet (London, England)
|August 16, 2011
PubMed
まとめ
この要約は機械生成です。

慢性腎臓病 (CKD) は,腎臓の機能に影響を与える世界的な健康問題です. ルーティン検査による早期発見と,小球膜濾過率 (GFR) とアルブミヌーリアに基づく管理は,進行を遅らせ,結果を改善することができます.

さらに関連する動画

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
08:50

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat

Published on: July 3, 2013

Mouse Model of Acute to Chronic Kidney Disease Transition Induced by Renal Ischemia/Reperfusion Injury
07:02

Mouse Model of Acute to Chronic Kidney Disease Transition Induced by Renal Ischemia/Reperfusion Injury

Published on: February 10, 2026

関連する実験動画

Last Updated: May 30, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
08:50

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat

Published on: July 3, 2013

Mouse Model of Acute to Chronic Kidney Disease Transition Induced by Renal Ischemia/Reperfusion Injury
07:02

Mouse Model of Acute to Chronic Kidney Disease Transition Induced by Renal Ischemia/Reperfusion Injury

Published on: February 10, 2026

科学分野:

  • ネフロロジーは腎臓科
  • 公衆衛生は公衆衛生である.
  • 内科内科は,内科の内科である.

背景:

  • 慢性腎臓病 (CKD) は,腎臓の構造と機能に影響を与える様々な疾患を網羅しています.
  • 2002年のガイドラインは,CKDを一般内科医による早期介入を必要とする世界的な公衆衛生上の懸念事項として認識することで,重要な変化を示した.
  • 慢性腎臓病の管理と分類は,疾患の重症度に応じて段階的に行われ,臨床診断の並行で,球過濾率 (GFR) とアルブミヌーリアを使用します.

研究 の 目的:

  • 慢性腎臓病の世界的な負担について議論するために.
  • CKDの評価と管理のための勧告を概説する.
  • CKDケアにおける将来の課題と不確実性の領域を特定する.

主な方法:

  • CKDの臨床実務ガイドラインのレビュー.
  • CKDに関連する臨床試験からのデータの分析.
  • GFRとアルブミヌリアのレベルを含む診断基準の議論.

主要な成果:

  • CKDは,通常の実験室検査で検出できます.
  • 早期の介入は,病気の発症を予防し,進行を遅らせることができます.
  • 効果的な管理は合併症,心血管疾患のリスクを軽減し,生存率と生活の質を改善します.

結論:

  • CKDは,早期管理戦略を備えた公衆衛生アプローチを必要とします.
  • GFRとアルブミヌリアを用いたCKDのステージ決定は,効果的な治療に不可欠です.
  • 継続的な研究と臨床ガイドラインの遵守は,CKDの課題に対処するために不可欠です.